Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients

• Egile Nagusiak: Keunhyeong Bak (Egilea), Suhyeon Moon (Egilea), Minjung Ko (Egilea), Yeo Jin Choi (Egilea), Sooyoung Shin (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2023-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract A growing number of patients with metabolic disorders are receiving statin and antidiabetic therapies as comedications. A signal of increased risk of myotoxicity due to potential interactions between antidiabetics and statins has been detected in previous studies. To investigate the effects...